EWM
HRMY icon

Empirical Wealth Management’s Harmony Biosciences HRMY Stock Holding History

Empirical Wealth Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$431K Buy
11,831
+2,716
+30% +$85.7K 0.01% 738
2026
Q1 		$255K Buy
9,115
+2,155
+31% +$70.7K ﹤0.01% 856
2025
Q4 		$260K Buy
+6,960
New +$229K ﹤0.01% 747

Other funds holding HRMY

CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SCM
Sidoxia Capital Management Newport Beach, California $136M AUM
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Empirical Wealth Management's HRMY Position: Q2 2026 in Review

Empirical Wealth Management increased its Harmony Biosciences (HRMY) stake by 30% in Q2 2026, buying an estimated $85.7K and bringing the position to 11,831 shares worth $431K. The position accounts for 0.01% of the portfolio, ranked #738.

Empirical Wealth Management first reported a position in HRMY in Q4 2025 and has held it in 3 quarters since. 68 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Empirical Wealth Management held 11,831 shares of Harmony Biosciences worth $431K as of Q2 2026.
  • Empirical Wealth Management bought 2,716 Harmony Biosciences shares in Q2 2026, an estimated $85.7K.
  • Harmony Biosciences made up 0.01% of Empirical Wealth Management's portfolio in Q2 2026, its #738 holding.
  • Empirical Wealth Management first reported a position in Harmony Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 68 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.